Ratan Lab
Research Projects

You are here

Histone deacetylases inhibitors for neurotherapeutics

In Progress

Histone deaceytlase (HDAC) inhibitors are a promising therapeutic of neurological diseases. The research focuses on using HDAC inhibitors to block neurodegeneration and promote neurorepair. The acetylation of histone proteins increases gene expression, and by blocking the removal of acetyl groups, HDAC inhibitors elevate histone acetylation. As a result of HDAC inhibition, a large transcriptional response occurs, which appears to enhance neuronal survival. Researchers are interested in identifying which of the 11 Zn-dependent HDACs are most critical in order to promote the ideal gene expression profile for neuronal survival. Additionally, the effects of diet on the production of endogenous HDAC inhibitors is also being investigated specifically on how dietary interventions can be used to treat neurological diseases, including Alzheimer’s disease and stroke.


Conditions & Recovery

Motor Recovery Icon
Write and walk again.
Stroke icon
Stroke is the leading cause of disability in the U.S.
Neurodegenerative Diseases icon
Worldwide, 50 million people are living with Alzheimer's and other dementias.